v3.26.3
Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2024   30,663    
Balance at beginning of period at Dec. 31, 2024 $ 93,989 $ 3 $ 750,174 $ (656,188)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,054   3,054  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   3    
Issuance of common stock upon exercise of stock options 0   0  
Issuance of common stock upon vesting of restricted stock units (in shares)   156    
Issuance of common stock (in shares)   592    
Issuance of common stock 5,111   5,111  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   (58)    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (492)   (492)  
Net loss (12,813)     (12,813)
Balance at end of period (in shares) at Mar. 31, 2025   31,356    
Balance at end of period at Mar. 31, 2025 88,849 $ 3 757,847 (669,001)
Balance at beginning of period (in shares) at Dec. 31, 2024   30,663    
Balance at beginning of period at Dec. 31, 2024 93,989 $ 3 750,174 (656,188)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (69,392)      
Balance at end of period (in shares) at Sep. 30, 2025   35,695    
Balance at end of period at Sep. 30, 2025 91,056 $ 4 816,632 (725,580)
Balance at beginning of period (in shares) at Mar. 31, 2025   31,356    
Balance at beginning of period at Mar. 31, 2025 88,849 $ 3 757,847 (669,001)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,599   3,599  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   32    
Issuance of common stock upon exercise of stock options 180   180  
Issuance of common stock upon vesting of restricted stock units (in shares)   139    
Issuance of common stock (in shares)   3,081    
Issuance of common stock 35,766   35,766  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   (51)    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (595)   (595)  
Net loss (41,239)     (41,239)
Balance at end of period (in shares) at Jun. 30, 2025   34,557    
Balance at end of period at Jun. 30, 2025 86,560 $ 3 796,797 (710,240)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,812   3,812  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   2    
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 16,079 $ 1 16,078  
Stock Issued During Period, Shares, Warrants   611    
Issuance of common stock upon vesting of restricted stock units (in shares)   525    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   0    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (55)   (55)  
Net loss (15,340)     (15,340)
Balance at end of period (in shares) at Sep. 30, 2025   35,695    
Balance at end of period at Sep. 30, 2025 $ 91,056 $ 4 816,632 (725,580)
Balance at beginning of period (in shares) at Dec. 31, 2025 35,930 35,930    
Balance at beginning of period at Dec. 31, 2025 $ 94,875 $ 4 821,319 (726,448)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 4,421   4,421  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   9    
Issuance of common stock upon exercise of stock options 7   7  
Issuance of common stock upon vesting of restricted stock units (in shares)   324    
Issuance of common stock (in shares)   631    
Issuance of common stock 14,204   14,204  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock   (127)    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (3,039)   (3,039)  
Net loss (29,663)     (29,663)
Balance at end of period (in shares) at Mar. 31, 2026   36,767    
Balance at end of period at Mar. 31, 2026 $ 80,805 $ 4 836,912 (756,111)
Balance at beginning of period (in shares) at Dec. 31, 2025 35,930 35,930    
Balance at beginning of period at Dec. 31, 2025 $ 94,875 $ 4 821,319 (726,448)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (31,982)      
Balance at end of period (in shares) at Sep. 30, 2026 41,102 41,102    
Balance at end of period at Sep. 30, 2026 $ 235,000 $ 4 993,426 (758,430)
Balance at beginning of period (in shares) at Mar. 31, 2026   36,767    
Balance at beginning of period at Mar. 31, 2026 80,805 $ 4 836,912 (756,111)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 4,609   4,609  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   89    
Issuance of common stock upon exercise of stock options 798   798  
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 333   333  
Stock Issued During Period, Shares, Warrants   7    
Issuance of common stock upon vesting of restricted stock units (in shares)   209    
Issuance of common stock (in shares)   3,556    
Issuance of common stock 145,821   145,821  
Net loss (20,834)     (20,834)
Balance at end of period (in shares) at Jun. 30, 2026   40,628    
Balance at end of period at Jun. 30, 2026 211,532 $ 4 988,473 (776,945)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 4,963   4,963  
Issuance of common stock upon exercise of stock options and ESPP shares purchased (in shares)   4    
Issuance of common stock upon vesting of restricted stock units (in shares)   470    
Issuance of common stock (10)   (10)  
Net loss $ 18,515     18,515
Balance at end of period (in shares) at Sep. 30, 2026 41,102 41,102    
Balance at end of period at Sep. 30, 2026 $ 235,000 $ 4 $ 993,426 $ (758,430)